Successful engraftment after reduced-intensity umbilical cord blood transplantation for myelofibrosis

Blood

Volumn 116, Issue 4, 2010, Pages 649-652

  Takagi, Shinsuke ^a   Ota, Yasunori ^a   Uchida, Naoyuki ^a   Takahashi, Koichi ^a   Ishiwata, Kazuya ^a   Tsuji, Masanori ^a   Yamamoto, Hisashi ^a   Asano Mori, Yuki ^a   Matsuno, Naofumi ^a   Masuoka, Kazuhiro ^b   Wake, Atsushi ^a   Miyakoshi, Shigesaburo ^c   Ohashi, Kenichi ^a   Taniguchi, Shuichi ^a,d  

^a TORANOMON HOSPITAL   (Japan)

^b Mishuku Hospital   (Japan)

^c Tokyo Metropolitan Institute of Gerontology   (Japan)

^d Okinaka Memorial Institute for Medical Research   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; FLUDARABINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; BUSULFAN; DRUG DERIVATIVE; MELPHALAN; MYELOABLATIVE AGENT; VIDARABINE;

ADULT; AGED; ARTICLE; CHIMERA; CLINICAL ARTICLE; CORD BLOOD STEM CELL TRANSPLANTATION; ENGRAFTMENT; FEMALE; GRAFT VERSUS HOST REACTION; HUMAN; MALE; MYELOFIBROSIS; NEUTROPHIL; PRIORITY JOURNAL; REDUCED INTENSITY CONDITIONING; THROMBOCYTE; UMBILICAL CORD BLOOD; CLINICAL TRIAL; FEASIBILITY STUDY; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; METHODOLOGY; MIDDLE AGED; MORTALITY; MYELOID METAPLASIA; RADIATION DOSE; REMISSION; SALVAGE THERAPY; SURVIVAL; TREATMENT OUTCOME; WHOLE BODY RADIATION;

AGED; BUSULFAN; CORD BLOOD STEM CELL TRANSPLANTATION; FEASIBILITY STUDIES; FEMALE; GRAFT SURVIVAL; HUMANS; MALE; MELPHALAN; MIDDLE AGED; MYELOABLATIVE AGONISTS; PRIMARY MYELOFIBROSIS; RADIOTHERAPY DOSAGE; REMISSION INDUCTION; SALVAGE THERAPY; SURVIVAL ANALYSIS; TRANSPLANTATION CONDITIONING; TREATMENT OUTCOME; VIDARABINE; WHOLE-BODY IRRADIATION;

EID: 77956022277     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-11-252601     Document Type: Article

References (22)

1. Zang DY, Deeg HJ. Allogeneic hematopoietic cell transplantation for patients with myelofibrosis. Curr Opin Hematol. 2009;16(2):140-146.
2. Guardiola P, Anderson JE, Bandini G, et al. Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Societe Francaise de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study. Blood. 1999;93(9):2831-2838.
3. Deeg HJ, Gooley TA, Flowers ME, et al. Allogeneic hematopoietic stem cell transplantation for myelofibrosis. Blood. 2003;102(12):3912-3918. (Pubitemid 37486970)
4. Daly A, Song K, Nevill T, et al. Stem cell transplantation for myelofibrosis: a report from two Canadian centers. Bone Marrow Transplant. 2003;32(1):35-40.
5. Rondelli D, Barosi G, Bacigalupo A, et al. Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia. Blood. 2005;105(10):4115-4119. (Pubitemid 40656163)
6. Snyder DS, Palmer J, Stein AS, et al. Allogeneic hematopoietic cell transplantation following reduced intensity conditioning for treatment of myelofibrosis. Biol Blood Marrow Transplant. 2006;12(11):1161-1168.
7. Kroger N, Zabelina T, Schieder H, et al. Pilot study of reduced-intensity conditioning followed by allogeneic stem cell transplantation from related and unrelated donors in patients with myelofibrosis. Br J Haematol. 2005;128(5):690-697. (Pubitemid 40343239)
8. Merup M, Lazarevic V, Nahi H, et al. Different outcome of allogeneic transplantation in myelofibrosis using conventional or reduced-intensity conditioning regimens. Br J Haematol. 2006;135(3):367-373.
9. Barker JN, Davies SM, DeFor T, Ramsay NK, Weisdorf DJ, Wagner JE. Survival after transplantation of unrelated donor umbilical cord blood is comparable to that of human leukocyte antigen-matched unrelated donor bone marrow: results of a matched-pair analysis. Blood. 2001;97(10):2957-2961.
10. Laughlin MJ, Eapen M, Rubinstein P, et al. Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia. N Engl J Med. 2004;351(22):2265-2275.
11. Rocha V, Labopin M, Sanz G, et al. Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004;351(22):2276-2285. (Pubitemid 39552743)
12. Takahashi S, Iseki T, Ooi J, et al. Single-institute comparative analysis of unrelated bone marrow transplantation and cord blood transplantation for adult patients with hematologic malignancies. Blood. 2004;104(12):3813-3820.
13. Wagner JE, Barker JN, DeFor TE, et al. Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood. 2002;100(5):1611-1618.
14. Gluckman E, Rocha V, Arcese W, et al. Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice. Exp Hematol. 2004;32(4):397-407.
15. Terakura S, Azuma E, Murata M, et al. Hematopoietic engraftment in recipients of unrelated donor umbilical cord blood is affected by the CD34+ and CD8+ cell doses. Biol Blood Marrow Transplant. 2007;13(7):822-830. (Pubitemid 46902438)
16. Rajantie J, Sale GE, Deeg HJ, et al. Adverse effect of severe marrow fibrosis on hematologic recovery after chemoradiotherapy and allogeneic bone marrow transplantation. Blood. 1986;67(6):1693-1697.
17. Thiele J, Kvasnicka HM, Tefferi A, Barosi G, Orazi A, Vardiman JW. Primary myelofibrosis. In: World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues, 4th edition. Lyon, France: IARC Press; 2008:44-47.
18. Kishi Y, Kami M, Miyakoshi S, et al. Early immune reaction after reduced-intensity cord-blood transplantation for adult patients. Transplantation. 2005;80(1):34-40.
19. Matsuno N, Wake A, Uchida N, et al. Impact of HLA disparity in the graft-versus-host direction on engraftment in adult patients receiving reduced-intensity cord blood transplantation. Blood. 2009;114(8):1689-1695.
20. Takagi S, Masuoka K, Uchida N, et al. High incidence of haemophagocytic syndrome following umbilical cord blood transplantation for adults. Br J Haematol. 2009;147(4):543-553.
21. Kaplan E, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
22. Rondelli D. Allogeneic hematopoietic stem cell transplantation for myelofibrosis. Haematologica. 2008;93(10):1449-1450.